RAPS RAC-GS Questions Answers
Regulatory Affairs Certification (RAC) Global Scope- 100 Questions & Answers
- Update Date : October 19, 2026
Prepare for RAPS RAC-GS with SkillCertExams
Getting RAC-GS certification is an important step in your career, but preparing for it can feel challenging. At skillcertexams, we know that having the right resources and support is essential for success. That’s why we created a platform with everything you need to prepare for RAC-GS and reach your certification goals with confidence.
Your Journey to Passing the Regulatory Affairs Certification (RAC) Global Scope RAC-GS Exam
Whether this is your first step toward earning the Regulatory Affairs Certification (RAC) Global Scope RAC-GS certification, or you're returning for another round, we’re here to help you succeed. We hope this exam challenges you, educates you, and equips you with the knowledge to pass with confidence. If this is your first study guide, take a deep breath—this could be the beginning of a rewarding career with great opportunities. If you’re already experienced, consider taking a moment to share your insights with newcomers. After all, it's the strength of our community that enhances our learning and makes this journey even more valuable.
Why Choose SkillCertExams for RAC-GS Certification?
Expert-Crafted Practice Tests
Our practice tests are designed by experts to reflect the actual RAC-GS practice questions. We cover a wide range of topics and exam formats to give you the best possible preparation. With realistic, timed tests, you can simulate the real exam environment and improve your time management skills.
Up-to-Date Study Materials
The world of certifications is constantly evolving, which is why we regularly update our study materials to match the latest exam trends and objectives. Our resources cover all the essential topics you’ll need to know, ensuring you’re well-prepared for the exam's current format.
Comprehensive Performance Analytics
Our platform not only helps you practice but also tracks your performance in real-time. By analyzing your strengths and areas for improvement, you’ll be able to focus your efforts on what matters most. This data-driven approach increases your chances of passing the RAC-GS practice exam on your first try.
Learn Anytime, Anywhere
Flexibility is key when it comes to exam preparation. Whether you're at home, on the go, or taking a break at work, you can access our platform from any device. Study whenever it suits your schedule, without any hassle. We believe in making your learning process as convenient as possible.
Trusted by Thousands of Professionals
Over 10000+ professionals worldwide trust skillcertexams for their certification preparation. Our platform and study material has helped countless candidates successfully pass their RAC-GS exam questions, and we’re confident it will help you too.
What You Get with SkillCertExams for RAC-GS
Realistic Practice Exams: Our practice tests are designed to the real RAC-GS exam. With a variety of practice questions, you can assess your readiness and focus on key areas to improve.
Study Guides and Resources: In-depth study materials that cover every exam objective, keeping you on track to succeed.
Progress Tracking: Monitor your improvement with our tracking system that helps you identify weak areas and tailor your study plan.
Expert Support: Have questions or need clarification? Our team of experts is available to guide you every step of the way.
Achieve Your RAC-GS Certification with Confidence
Certification isn’t just about passing an exam; it’s about building a solid foundation for your career. skillcertexams provides the resources, tools, and support to ensure that you’re fully prepared and confident on exam day. Our study material help you unlock new career opportunities and enhance your skillset with the RAC-GS certification.
Ready to take the next step in your career? Start preparing for the RAPS RAC-GS exam and practice your questions with SkillCertExams today, and join the ranks of successful certified professionals!
RAPS RAC-GS Sample Questions
Question # 1According to ICH, which of the following components of study information is NOT required in a clinical study report?
A. Randomization scheme and codes
B. Protocol and protocol amendments
C. ListoflECsorlRBs
D. Detailed CVofall investigators
Question # 2
The manufacturer of an API was changed from Company X to Company Y during the late stage of a new drug development. Despite differences in the manufacturing processes of the companies, both APIs meet the current specifications. Which is the MOST appropriate information to include in the final submission documents?
A. The process information and analytical result of Company X API
B. The process information and analytical result of Company Y API
C. The process information and the comparative analytical result of APIs from both
companies
D. Information deemed appropriate by the regulatory authority
Question # 3
Which of the following BEST describes the content of the "Physical, Chemical, and Pharmaceutical Properties and Formulation" section of an IB?
A. A review of available data to support the determination of the chemical structure and
physical attributes of the drug substance plus batch analysis and stability data for the
finished formulation
B. A detailed summary of the physical and chemical properties of the drug product with a
signed expert statement addressing the suitability and stability of the formulation for its
intended use
C. A description and flow chart illustrating the synthetic route for the active ingredient and
the preparation method of the finished product
D. A brief summary of relevant physical, chemical, and pharmaceutical properties:
instructions for storage and handling of the dosage form: and a description of the formulation
Question # 4
As part of the regulatory strategy for companies intending to manufacture a psychotropic product, which of the following approvals should be received FIRST?
A. Site license
B. Product license
C. Import license
D. Export license
Question # 5
What are the MOST important elements that global regulatory agencies want to know before approving a new product for sale in their countries?
A. Safety and failure risk
B. Safety and effectiveness
C. Quality and failure risk
D. Quality and effectiveness
Question # 6
In the process of obtaining a product approval, a regulatory affairs professional discovers that the product does not meet one of the specific technical requirements of the regulation. However, competitors with substantially similar products have claimed compliance with the requirement and received approval. Which action should the regulatory affairs professional take FIRST?
A. Discuss with the regulatory apriority and attempt to reach an acceptable solution.
B. Inform the internal departments to redesign the product to comply with this requirement.
C. Inform the regulatory authority that such a requirement is not applicable to the product.
D. Notify senior management that the product cannot be registered.
Question # 7
Which analysis method is MOST appropriate to prioritize risk and monitor the effectiveness of risk control activities for a medical device?
A. Fishbone analysis
B. Failure modes, effects, and criticality analysis
C. Fault tree analysis
D. Quality by design analysis
Question # 8
Which of the following double-blind clinical trial designs would be MOST appropriate for a Phase III study with a new product intended to treat an acute life-threatening disease with less than optimal available therapy?
A. Active-controlled
B. Cross-over
C. Dose-ranging
D. Placebo-controlled
Question # 9
During new drug development, a new impurity in the drug substance is detected at a level of 0.12%. The intended maximum daily dose Is less than 2 g/day, and the drug Is known generally not to be toxic. What should be done in response to identifying the impurity?
A. Perform either an identification study or a non-clinical qualification study.
B. Perform both identification and non-clinical qualification studies concurrently.
C. Perform an identification study, wait until the result is available, and then consider performing a non-clinical qualification study.
D. Perform a non-clinical qualification study, wait until the result is available, and then
consider performing an identification study.
Question # 10
A manufacturer is involved in a recall event process for a plasma-derived product. From which stage should the manufacturer be able to trace back the product?
A. Plasma fractionation
B. Product distribution
C. Individual plasma donation
D. Plasma pooling
Question # 11
The requirements for document control are located in which of the following documents?
A. ICH guidelines
B. IEC 60601
C. ISO 13485
D. WHO guidelines
Question # 12
Which of the following criteria is MOST appropriate to define the animal species needed for the pre-clinical toxicity testing of a biotechnology product?
A. Proposed dose and volume of administration
B. Biological activity with species and/or tissue specificity
C. Immunochemical and functional tests
D. Proposed product route and frequency of administration
Question # 13
A company is developing a new medical device. During which initial stage is it MOST appropriate (or a regulatory affairs professional to become involved?
A. Concept development and validation
B. Concept development and early technical design
C. Early technical design and product release
D. Product release and validation
Question # 14
During face-to-face meetings with the regulatory authority to address submission issues, what is the BEST choice for the number of company representatives who should attend?
A. The minimum number of attendees necessary to address the issues
B. All senior management from the main office
C. As many as government attendees
D. As many as required by international standards
Question # 15
GHTF recommends that the medical device manufacturer define the scope of the clinical evaluation based on which of the following?
A. Instructions for use
B. Risk analysis
C. Product literature
D. Essential principles